Neonatal disorders often present with non-specific symptoms that make diagnosis challenging. CMA provides a more detailed genetic analysis, allowing for the detection of subtle chromosomal changes that might be missed by other diagnostic methods. This can lead to early and accurate diagnosis, enabling timely intervention and management.
